A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

Completed

• Conditions: Common Cold; Hypersensitivity; Sinusitis

• Registration Number: NCT05126407
• Lead Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)

Brief Summary

The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-03
• Study First Submitted QC: 2021-11-18
• Study First Posted: 2021-11-19
• Study Start: 2021-12-17
• Primary Completion: 2022-01-20
• Study Completion: 2022-01-20
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-31
• Last Update Posted: 2023-02-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

• Aged 18 years or older who has personally used or administered the nasal drops/spray to a child
• Has personally used or administered to a child, the Nasal Drops/Spray at least once within the past 6 months
• Able to read, write, speak, and understand German
• Has internet access to complete an on-line survey
• Intends to complete the survey
• Individual has signed the informed consent document (ICD)

Exclusion Criteria

• Is an employee/contractor or immediate family member of the principal investigator (PI), Schlesinger group, product perceptions limited (PPL) Insights or sponsor of this study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Spray	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Nasal Saline Spray will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Ectomed Nasal Spray	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Ectomed Nasal Spray will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Drops	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Nasal Saline Drops will be assessed via electronic survey.
Number of Participants with Adverse Events (AEs)	Up to 1 month and 14 days	An AE is any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in participants, users or other persons, whether or not related to the investigational device.

Trial Locations

Locations (1)

Schlesinger Group; 🇩🇪 Berlin, Germany